Healthcare Realty 10-Q Details Q3 FFO of $0.42, $58.9M Impairments and $225M of Buybacks
HR is trading near its 52-week low of $16.31 (11% above the low).
Summary
Healthcare Realty's Q3 10-Q backs up the same-day earnings release: normalized FFO of $0.42 per share, a $59.3 million nine-month GAAP net loss on $57.9 million of impairments, and $225.1 million of shares repurchased year to date.
Key Events · Earnings and Guidance · HR
-
Q3 Normalized FFO $0.42 Per Share
Normalized FFO attributable to common stockholders was $145.9 million, or $0.42 per diluted share, versus $145.3 million and $0.41 in Q3 2025; NAREIT FFO was $0.38 per share.
-
Nine-Month GAAP Loss on Impairments
Net loss attributable to common stockholders was $59.3 million ($0.18 per share) for the nine months, including $57.9 million of real-estate impairments, down from $260.5 million a year earlier when impairments were $255.4 million.
-
$225M of Buybacks Funded by Exchangeable Notes
The company repurchased 12.3 million shares for $225.1 million in the first nine months (5.7M at $17.38, 3.8M at $19.58, 2.8M at $18.07), and another 1.5 million at $17.13 for $24.9 million in October; $350.2 million remained on the prior authorization at quarter-end.
-
Debt Refinanced With $700M Exchangeable Notes
Notes and bonds payable rose to $4.25 billion from $3.91 billion after the May 2026 $700 million 3.00% exchangeable notes issue (exchange price $23.01) repaid the 2026 maturities; $1.6 billion was available across the delayed-draw term loan and revolver net of $347.5 million of commercial paper.
Analysis · HR · Real Estate & Construction
The 10-Q is the full financial backing for the same-day Q3 release: normalized FFO of $0.42 per share versus $0.41 a year ago, with the headline guidance raise already out. What the quarterly report adds is the balance-sheet detail — $4.25 billion of notes and bonds payable after the May 2026 $700 million 3.032% exchangeable notes issue that retired the 2026 maturities, $1.6 billion of combined revolver and delayed-draw capacity, and $225.1 million of stock repurchased in the first nine months at an average that has run below today's $18.13. Against that, GAAP net loss was $59.3 million for the nine months, driven by $57.9 million of real-estate impairments, and cash flow from operations slipped to $317.3 million from $324.8 million. The buyback is the offset to dilution: 12.3 million shares retired in nine months against 4.2 million OP units still outstanding.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HR was trading at $18.13 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $6.2B. The 52-week trading range was $16.31 to $22.04. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.